Showing 761-770 of 2280 results for "".
Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.The Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-prognostic-utility-of-neurofilament-light-chain-in-multiple-sclerosis-a-narrative-review/32098/Neurofilament light chain has great promise as a prognostic biomarker in multiple sclerosis.Managing Mood Disorders, Behavioral Changes, and Psychosis in People Living with Vascular Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/managing-mood-disorders-behavioral-changes-and-psychosis-in-people-living-with-vascular-dementia/36649/This article explores the neuropsychiatric symptoms associated with vascular dementia, including their underlying mechanisms, clinical implications, and potential management strategies.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.Antiplatelet Therapies After Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/antiplatelet-therapies-after-ischemic-stroke/31862/Antiplatelet therapies are effective for prevention of secondary stroke and can be tailored to individual patient needs.Managing Symptoms of Depression, Apathy, Psychosis, and Agitation in People Living with Alzheimer Disease
https://practicalneurology.com/archives/aug-2025-issue/managing-symptoms-of-depression-apathy-psychosis-and-agitation-in-people-living-with-alzheimer-disease/36689/Optimal treatment of neuropsychiatric symptoms in Alzheimer disease necessitates early identification, rigorous clinical differentiation, and the development of individualized therapeutic approaches.Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer's Disease?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/are-anti-amyloid-therapies-still-worth-being-developed-as-treatments-for-alzheimers-disease/30832/Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer's and delay disease progression.Behavioral Approaches in Dementia Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/behavioral-approaches-in-dementia-care/31800/The many behavioral and psychologic symptoms of dementia have a large effect on patient and caregiver outcomes.Physical and Cognitive Activity for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/physical-and-cognitive-activity-for-dementia/31733/There is enough evidence of the neuroprotective effects of physical and cognitive activity to recommend these to patients.- Remembering Ronald DeVere, MD, FAANhttps://practicalneurology.com/news/remembering-ronald-devere-md-faan/2470936/Ronald DeVere, MD, FAAN, Practical Neurology Editorial Advisory Board member and former Editor of the Dementia Insights column, passed away on May 8, 2024, at age 80. Dr. DeVere served as the Director of the Taste & Smell Disorders Clinic and the Alzheimer Disease & Memory Disorder